Adar Poonawalla, chief executive of the Serum Institute of India, on vaccines, regulation and what comes next

Adar Poonawalla, 40, is the chief executive of the Serum Institute of India (SII), the Pune-based, family-owned vaccine manufacturer that is producing more Covid-19 vaccines by dose than any other in the world. For now it’s the Oxford/AstraZeneca vaccine rolling off its production lines, but SII has signed contracts with three other developers – Novavax, Codagenix and SpyBiotech – all of which have candidates in the works.

Did you ever imagine you would be making vaccines for a global pandemic?

Continue reading…

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Price rises lift Unilever sales; markets await ECB interest rate decision and US GDP – business live

Rolling coverage of the latest economic and financial news Ex-NatWest chief breached…

Reality bites: Could Jurassic Park actually happen?

Spielberg might have claimed the 90s classic ‘depends on credibility’ – but…

Labour ‘must spend billions on welfare or poverty will soar’

Britain’s benefits system needs urgent reform, at a cost of £12bn, charities…